AirSculpt Technologies, Inc. (AIRS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK–(BUSINESS WIRE)–
Investigation Details:
On or around October 29, 2021, AirSculpt conducted its initial public offering (“IPO”), selling 7 million shares of common stock priced at $11.00 per share. Then, on February 23, 2024, Fuzzy Panda Research issued a report alleging that AirSculpt has “lie[d] to patients” about a patient death, has “[s]uspect doctors with questionable credentials,” and has used employees to “pos[e] as patients” in online reviews. On this news, AirSculpt’s stock price fell sharply during intraday trading on February 23, 2024.
What’s Next?
If you are aware of any facts relating to this investigation or purchased AirSculpt securities, you can assist this investigation by visiting the firm’s site: bgandg.com/AIRS. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman:
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
332-239-2660 | [email protected]
